CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024		16,487
Beginning balance at Dec. 31, 2024	$ 470,952	$ 165	$ 2,057,852	$ (1,586,977)	$ (88)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	12,112			12,112
Other comprehensive income (loss)	631				631
Vesting of restricted stock units (in shares)		34
Shares withheld related to net share settlement (in shares)		(1)
Shares withheld related to net share settlement	(161)		(161)
Stock-based compensation expense	16,720		16,720
Ending balance (in shares) at Mar. 31, 2025		16,520
Ending balance at Mar. 31, 2025	$ 500,254	$ 165	2,074,411	(1,574,865)	543
Beginning balance (in shares) at Dec. 31, 2025	16,589	16,589
Beginning balance at Dec. 31, 2025	$ 126,734	$ 166	2,103,976	(1,978,324)	916
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	48,916			48,916
Other comprehensive income (loss)	(437)				(437)
Vesting of restricted stock units (in shares)		19
Shares withheld related to net share settlement (in shares)		(2)
Shares withheld related to net share settlement	(35)		(35)
Stock-based compensation expense	$ 6,255		6,255
Ending balance (in shares) at Mar. 31, 2026	16,606	16,606
Ending balance at Mar. 31, 2026	$ 181,433	$ 166	$ 2,110,196	$ (1,929,408)	$ 479